Denali Therapeutics Inc. (4DN)
Market Closed
4 Jun, 20:00
XFRA 
€
16. 71
+0.37
+2.2331%
€
- Market Cap
- P/E Ratio
- Div Yield
80 Volume
-1.08 Eps
€ 16.34
Previous Close Want to track 4DN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
4DN Earnings Reports FAQ
What is the earnings per share (EPS) for 4DN?
The current EPS is -1.08.
What is the company's earnings growth rate?
Denali Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Denali Therapeutics Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Denali Therapeutics Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 4DN at this time, as Denali Therapeutics Inc has no recent EPS data to calculate it.
